Print Page

Products found to contain undeclared medicines

Australia: Safety advisory: Lose Weight Capsules were found contain undeclared sibutramine and diclofenac
The Therapeutic Goods Administration (TGA) has tested a product labelled Lose weight capsules and found that the capsules contain the undeclared substances sibutramine and diclofenac.

Consumers are advised that sibutramine is a prescription-only medicine (which was the active ingredient in Reductil). It was withdrawn in October 2010 after a study showed an increased risk of major cardiac events. Consumers are also advised that diclofenac as a non-steroidal anti-inflammatory drug (NSAID), is currently available in Australia as an over the counter medication or prescription-only medicine dependant on the preparation size. Lose

Weight capsules pose a serious risk to health and should not be taken. TGA investigations have shown that a number of people in Australia may have bought the product online.

Consumers are advised to stop taking the product and consult their health care practitioner if they have any concerns arising from the use of the product.

Please refer to the following website in TGA for details:

In Hong Kong, the above product is not a registered pharmaceutical product.

Ends/Tuesday, April 11, 2017
Issued at HKT 15:00
Related Information:
Canada: Foreign Product Alert: Lose Weight capsules, Nangen Zengzhangsu, PHQ 100... Posted 2017-06-10
Australia: Safety advisory: Slim-Vie Slimming Capsules were found to contain und... Posted 2017-04-21
Australia: Safety advisory: Nangen Zengzhangsu capsules were found to contain un... Posted 2017-04-10
Singapore: HSA Alert: Consumer developed diabetes & other adverse reactions afte... Posted 2017-04-05